跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-PERINDOPRIL/INDAPAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-PERINDOPRIL/INDAPAMIDE
Authorized
STANDARD
TEVA-PERINDOPRIL/INDAPAMIDE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e5f05ea3d676d6d1
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
e5f05ea3d676d6d1
Drug Approval Canada Name
TEVA-PERINDOPRIL/INDAPAMIDE
Product Name
TEVA-PERINDOPRIL/INDAPAMIDE
Status
Marketed
Status Date
2018-03-07
Original Market Date
2018-03-07
Din
02464039
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09BA04 PERINDOPRIL AND DIURETICS
Atc Name
c 09 ba 04
Aig Number
0248401003
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
INDAPAMIDE
2.5 MG
PERINDOPRIL ERBUMINE
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e5f05ea3d676d6d1
Type
Standard
Back to Health Canada Approvals